10.01.2017 • NewsbeveragebiocontrolBioControl Systems

Merck KGaA Buys Food Safety Firm BioControl

(c) BioControl
(c) BioControl

German pharmaceuticals and chemicals producer Merck KGaA has acquired US-based BioControl Systems, a leading player in food safety testing. Merck said the acquisition, for which term are being kept confidential, opens growth opportunities for food pathogen testing in the US food and beverage sector in particular.

BioControl’s established rapid detection technology and third-party validated testing platforms complement will allow Merck to offer complete workflow solutions for food pathogen testing, the Darmstadt company said. Together with Merck’s strengths in microbiology, filtration and e-commerce, the “innovative assays and validated kits” produced by the Bellevue, Washingon-based  firm with $34 million in annual sales will establish a strong global presence in food pathogen testing solutions, said Udit Batra, member of the Merck executive board and CEO, Life Sciences.

Batra said the global spotlight on the importance of food safety has grown with the increased incidents of outbreaks and recalls due to food-borne diseases. The pathogen detection kits produced by BioControl – whose key customers are in the meat industry – can help to identify bacteria in foods and ingredients such as undercooked meat, eggs, fresh produce and dairy products contaminated by Salmonella, Listeria, E.coli O157H7 and Campylobacter, he added.

Phil Feldsine, CEO of BioControl, commented that Merck’s global market presence as a leader in laboratory sciences will introduce customer oriented solutions to a much broader base worldwide while providing existing customers with access to the German group’s food safety product portfolio and expertise.

Merck said the acquisition is in line with its life science arm’s goal of expanding in key geographies and providing “a differentiated experience” to customers in applied settings, including food and beverage safety testing while it continues to focus on microbial quality control solutions for pharmaceutical production processes and products, where the business currently has a leading market share.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

most read

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.